Meet IDDI at ASCO Annual Meeting 2019
May 31, 2019 — June 4, 2019
Chicago, IL, USA
IDDI Oncology Experts at ASCO Annual Meeting 2019
Schedule some time to meet with IDDI Oncology Experts at ASCO 2019 to discuss your situation and see how we can help you achieve your goals faster!
Your work hard to develop novel anti-cancer therapies. We develop innovative strategies and have the focused capabilities needed to launch your products with the greatest potential for commercial success and patient outcomes. Our valuable therapeutic insight in cancer research, paired with data quality expertise, will make a critical difference to the outcome of your clinical trials.
MEET OUR EXPERTS
 |
 |
| Marc Buyse, ScD, Chief Scientific Officer, IDDI | Everardo Saad, MD, Medical Director, IDDI |
Leverage Our Oncology Expertise And Gain Efficiency In Your Oncology Trials
Coming from a scientific background, IDDI is an oncology CRO led by a highly-skilled biostatistical and clinical team of thought-leaders in oncology research. Our experts know the importance of keeping up to date with all the latest advances in the field of immunotherapy and oncology medicine. IDDI’s expertise lies in the right choice of endpoints, adequate definition of selection criteria and state-of-the-art statistical planning, and analysis and modelling tailored to oncology drug development needs.